Enovis Corp Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Enovis Corp (ENOV) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$54.84 million for the 3-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-01
- Enovis Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$54.84M.
- Enovis Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$65.95M.
- Enovis Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-07-01 was $120.65M.
- Enovis Corp income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-04-01 was -$38.05M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$54.84M 10-K · filed 2023-03-01 | -$120.78M derived: sum of 2 quarters · filed 2023-03-01 | -$134.00K derived: sum of 3 quarters · filed 2023-03-01 | -$38.19M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2022-09-30 | -$65.95M 10-K · filed 2023-03-01 | $54.70M derived: sum of 2 quarters · filed 2023-03-01 | $16.65M derived: sum of 3 quarters · filed 2023-03-01 | $1.95M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2022-07-01 | $120.65M 10-K · filed 2023-03-01 | $82.60M derived: sum of 2 quarters · filed 2023-03-01 | $67.90M derived: sum of 3 quarters · filed 2023-03-01 | $54.32M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2022-04-01 | -$38.05M 10-K · filed 2023-03-01 | -$52.75M derived: sum of 2 quarters · filed 2023-03-01 | -$66.33M derived: sum of 3 quarters · filed 2023-03-01 | -$108.45M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-12-31 | -$14.69M 10-K · filed 2023-03-01 | -$28.27M derived: sum of 2 quarters · filed 2023-03-01 | -$70.40M derived: sum of 3 quarters · filed 2023-03-01 | -$102.25M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-10-01 | -$13.58M 10-K · filed 2023-03-01 | -$55.70M derived: sum of 2 quarters · filed 2023-03-01 | -$87.56M derived: sum of 3 quarters · filed 2023-03-01 | -$46.04M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-07-02 | -$42.13M 10-K · filed 2023-03-01 | -$73.98M derived: sum of 2 quarters · filed 2023-03-01 | -$32.46M derived: sum of 3 quarters · filed 2023-03-01 | -$15.63M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-04-02 | -$31.85M 10-K · filed 2023-03-01 | $9.67M derived: sum of 2 quarters · filed 2023-03-01 | $26.50M derived: sum of 3 quarters · filed 2023-03-01 | $23.36M derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2020-12-31 | $41.52M 10-K · filed 2021-02-18 | $58.36M derived: sum of 2 quarters · filed 2021-02-18 | $55.21M derived: sum of 3 quarters · filed 2021-02-18 | $64.08M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2020-10-02 | $16.84M 10-K · filed 2021-02-18 | $13.69M derived: sum of 2 quarters · filed 2021-02-18 | $22.56M derived: sum of 3 quarters · filed 2021-02-18 | $56.97M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2020-07-03 | -$3.14M 10-K · filed 2021-02-18 | $5.73M derived: sum of 2 quarters · filed 2021-02-18 | $40.14M derived: sum of 3 quarters · filed 2021-02-18 | $43.91M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2020-04-03 | $8.87M 10-K · filed 2021-02-18 | $43.28M derived: sum of 2 quarters · filed 2021-02-18 | $47.05M derived: sum of 3 quarters · filed 2021-02-18 | $49.26M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2019-12-31 | $34.41M 10-K · filed 2021-02-18 | $38.18M derived: sum of 2 quarters · filed 2021-02-18 | $40.39M derived: sum of 3 quarters · filed 2021-02-18 | $18.86M derived: sum of 4 quarters · filed 2021-02-18 | |||
| 2019-09-27 | $3.77M 10-K · filed 2021-02-18 | $5.98M derived: sum of 2 quarters · filed 2021-02-18 | -$15.55M 10-Q · filed 2019-10-31 | ||||
| 2019-06-28 | $2.21M 10-K · filed 2021-02-18 | -$19.32M 10-Q · filed 2019-08-06 | |||||
| 2019-03-29 | -$21.53M 10-K · filed 2021-02-18 | -$44.56M 10-Q · filed 2019-05-08 | |||||
| 2018-09-28 | $16.66M 10-Q · filed 2019-10-31 | $37.90M 10-Q · filed 2018-10-25 | $64.50M derived: sum of 2 quarters · filed 2019-10-31 | $85.26M 10-Q · filed 2019-10-31 | $137.28M 10-Q · filed 2018-10-25 | ||
| 2018-06-29 | $47.84M 10-Q · filed 2019-08-06 | $67.51M 10-Q · filed 2018-08-06 | $68.60M 10-Q · filed 2019-08-06 | $99.39M 10-Q · filed 2018-08-06 | |||
| 2018-03-31 | $31.88M 10-Q · filed 2018-05-03 | ||||||
| 2018-03-30 | $31.88M 10-Q · filed 2019-05-08 | ||||||
| 2017-09-29 | $49.62M 10-Q · filed 2018-10-25 | $91.49M derived: sum of 2 quarters · filed 2018-10-25 | $129.88M 10-Q · filed 2018-10-25 | ||||
| 2017-06-30 | $41.86M 10-Q · filed 2018-08-06 | $80.25M 10-Q · filed 2018-08-06 | |||||
| 2017-03-31 | $38.39M 10-Q · filed 2018-05-03 | ||||||
| 2016-09-30 | $40.55M 10-Q · filed 2017-11-06 | $111.58M 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |